Hamilton Lane appoints Michael Schmertzler independent director to board

• Hamilton Lane elected Michael Schmertzler as an independent director, effective July 22, 2026.
• Schmertzler becomes the fifth independent director, joining three executive directors on the board.
• He is chairman and a director at PTC Therapeutics.
• He previously served as a managing director at Credit Suisse First Boston Equity Partners, including as investment committee chair.
• Earlier roles included managing director at Morgan Stanley, including president of Morgan Stanley Leveraged Capital Funds.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hamilton Lane Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202607230700PR_NEWS_USPR_____PH10224) on July 23, 2026, and is solely responsible for the information contained therein.